Evidence map›Paper›PMID 39452703›Full record

ReviewPathogens (Basel, Switzerland)2024

Orbital Myositis after Herpes Zoster Ophthalmicus: A Case Report and a Narrative Review of the Literature.

Edoardo Pace, Guido Accardo, Tommaso Lupia, Maria Felice Brizzi, Silvia Corcione, Francesco Giuseppe De Rosa

Abstract readCase ReportsReview
In one paragraph

Review in Pathogens (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Necrotizing orbital infections: A comprehensive review.Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Edoardo PaceDepartment of Medical Sciences, Internal Medicine, University of Turin, 10126 Turin, Italy.ORCID 0000-0002-0813-8181
Guido AccardoDepartment of Medical Sciences, Infectious Diseases, University of Turin, 10126 Turin, Italy.
Tommaso LupiaUnit of Infectious Disease 2U, University Hospital Città della Salute e della Scienza di Torino, 10100 Turin, Italy.ORCID 0000-0002-3865-9519
Maria Felice BrizziDepartment of Medical Sciences, Internal Medicine, University of Turin, 10126 Turin, Italy.ORCID 0000-0003-0944-6992
Silvia CorcioneDepartment of Medical Sciences, Infectious Diseases, University of Turin, 10126 Turin, Italy.
Francesco Giuseppe De RosaDepartment of Medical Sciences, Infectious Diseases, University of Turin, 10126 Turin, Italy.ORCID 0000-0001-8338-0130

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Herpes zoster ophthalmicus results from the reactivation of the latent varicella zoster virus, affecting the first branch of the trigeminal nerve. In 20-70% of cases, Zoster Ophthalmicus can lead to ocular involvement, affecting various orbital structures. Orbital myositis is a rare but severe complication of herpes zoster ophthalmicus. We present a case of a 52-year-old man with no significant medical history who developed zoster-associated right ocular myositis and dacryocystitis. He was treated with intravenous acyclovir and oral steroids. A review of the literature identified 29 patients across 19 studies. The median age was 61 years, with a slight female predominance. In 55% of cases, the patients had no notable medical history. The most common presentation of myositis involved all oculomotor muscles. There were 22 cases who were treated with intravenous antiviral therapy and 19 received steroids. A full resolution of symptoms was achieved in 51.7% of patients. Zoster-related orbital myositis is a rare complication that should be considered even in immunocompetent individuals. It may occur either before or after the appearance of a vesicular rash. Magnetic resonance imaging is the preferred radiological exam for assessing orbital involvement. Intravenous antiviral therapy should be started within 72 h of symptom onset, and its combination with systemic corticosteroids appears to be an effective treatment for zoster-related ocular myositis.

Indexed as

Antiviral AgentsHerpes Zoster OphthalmicusOrbital MyositisAcyclovirHerpesvirus 3, HumanHumansMagnetic Resonance ImagingMaleMiddle AgedAcyclovirAntiviral Agentsacyclovirherpes zostermyositisshingles

Identifiers

PMID39452703
PMCPMC11510548

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.